News | Mammography | September 17, 2015

Hologic’s Genius 3-D Mammography Continues to Lead U.S. Breast Tomosynthesis Market

KLAS Research finds Hologic stands out among mammography providers for technology innovation, high image quality and C-View dose-reduction technology

Hologic, Genius 3-D Mammography, KLAS Research, U.S. breast tomosynthesis market, C-View

Selenia Dimensions system with Genius 3-D Mammography image courtesy of Hologic.

September 17, 2015 — Hologic Inc. announced that U.S. mammography providers gave the company and its Genius 3-D Mammography exams top scores in a new study by KLAS Research, titled Women’s Imaging 2015: Are New Technologies Delivering Promised Benefits?

In the study, mammography providers scored Hologic highest in all 11 performance measures evaluated by KLAS.  For example:

  • 95 percent of users said they would buy from Hologic again; and
  • 67 percent of users said Hologic was their best mammography vendor.

The researchers noted that Hologic 3-D Mammography stands out for technology innovation and high image quality, and that its C-View software is strengthening satisfaction and encouraging adoption. 

The KLAS study found significant movement in the mammography space thanks to the advent of breast tomosynthesis technology. For example, 65 percent of the providers surveyed planned to invest in breast tomosynthesis technology during the next two years, up from 57 percent in 2014. The study notes that many respondents who said they did not intend to purchase had already upgraded to tomosynthesis.

Clinical studies have shown that a Hologic Genius 3-D Mammography exam using the company’s low-dose software is superior to 2-D exams alone for all breast types, improving diagnostic accuracy while also reducing recalls. With C-View software, facilities can offer a better exam at an equivalent dose to 2-D alone.

For more information:

Related Content

Keith Dreyer, DO, said artificial intelligence is one of the most important developments to watch in radiology at the opening session of RSNA 2016.

Keith Dreyer, DO,  said artificial intelligence is one of the most important developments to watch in radiology at the opening session of RSNA 2016.

Feature | Artificial Intelligence | November 17, 2017
November 16, 2017 — The American College of Radiology Data Science Institute (DSI) will provide the framework, strate
Biop Medical Launches Cervical Cancer Diagnosis Technology at MEDICA 2017

Biop Medical cervical cancer detection system

Technology | Women's Health | November 13, 2017
November 13, 2017 — Biop Medical announced it will present its point-of-care...
Kansas City Radiology Center Employs iCAD PowerLook Tomo Detection for DBT
News | Computer-Aided Detection Software | November 10, 2017
November 10, 2017 — Imaging for Women, a leading radiology center in Kansas City, Mo., announced it is now using iCAD
Kubtec Brings Image Analytics Capabilities to Tomosynthesis Specimen Imaging Systems
News | Mammography | November 10, 2017
Kubtec announced it will be showcasing new image analytics capabilities on its advanced tomosynthesis specimen imaging...
Siemens Healthineers Introduces Share360 Tailored Service Portfolio
News | Imaging | November 10, 2017
November 10, 2017 — To address the specific needs of...
Fujifilm Highlights Women's Health and Pediatrics at RSNA 2017
News | Information Technology | November 08, 2017
November 8, 2017 — Fujifilm Healthcare will showcase a variety of imaging and information technology solutions at the
CureMetrix Expands Medical Advisory Board
News | Computer-Aided Detection Software | November 08, 2017
November 8, 2017 — CureMetrix, a company developing...
ICPME Makes EQUIP Mammography Inspection CME/CE Webinar Available Online
News | Mammography | November 08, 2017
November 8, 2017 — In conjunction with Brea...
Study Suggests Breast Cancer Patients Forego Post-Surgery Treatment Due to Mistrust
News | Radiation Therapy | November 06, 2017
November 6, 2017 — Nearly one-third of women with...
Study shows tissue marker reduces radiation target volumes, produces many other advantages

These CT images show placement of a 3-D fixed array implanted fiducial (3-D marker) at the time of oncoplastic tumor resection. The original LCTV (LCTVo) was retrospectively re-contoured by the radiation oncologist (LCTVro) and breast surgeon (LCTVbs). Thereafter, both re-contours were combined to create the collaborative LCTV (LCTVc), which required agreement of both the radiation oncologist and breast surgeon. Volume differences between the original LCTV (LCTVo) and the collaborative LCTVc were then evaluated, and demonstrated a mean and median reduction in LCTV.

Feature | Tumor Tracking Systems | November 06, 2017 | By William Hall, M.D.
Radiation planning for breast cancer relies on accurate delineation of the post-lumpectomy target volume as identified...
Overlay Init